Generics in the Netherlands
Description
Generics>in>the>Netherlands
Summary
>Generics>in>the>Netherlands>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>share,>market>size>(value>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
Summary
>Generics>in>the>Netherlands>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>share,>market>size>(value>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
- A>generic>drug>is>defined>as>a>copy>of>an>ethical>(prescription)>drug>formerly>protected>by>patents>that>have>now>expired.>Both>unbranded>generics>and>branded>generics>are>included>in>our>market>scope.>However,>off-patent>drugs>that>continue>to>be>offered>by>the>original>manufacturer>under>the>original>name,>and>which>form>part>of>the>'generic-eligible'>market,>are>not>included.>Market>value>is>evaluated>at>ex-factory>prices.>Market>volume>refers>to>the>proportion>of>the>total>ethical>pharmaceutical>market>in>a>country>or>region>that>is>made>up>of>generic>drugs.>Thus,>it>is>a>measure>of>the>market>share>held>by>generics,>rather>than>a>direct>measure>of>the>total>market>volume.>Regional>volumes>are>calculated>as>averages>of>countries>that>comprise>the>region>where>volume>data>exists.
- The>Dutch>generics>market>recorded>revenues>of>$3.0>billion>in>2024,>representing>a>compound>annual>growth>rate>(CAGR)>of>3.3%>between>2019>and>2024.
- Market>consumption>volume>increased>with>a>CAGR>of>0.5%>between>2019>and>2024,>reaching>a>total>of>79.4>%>of>total>pharma>volume>in>2024.
- In>2024,>the>revenue>of>the>Dutch>generics>market>experienced>an>annual>growth>of>4.3%.>The>market’s>growth>is>driven>by>the>rising>prevalence>of>chronic>diseases>such>as>diabetes,>hypertension,>and>cardiovascular>conditions,>increasing>the>demand>for>affordable,>long-term>medications.
- Save>time>carrying>out>entry-level>research>by>identifying>the>size,>growth,>major>segments,>and>leading>players>in>the>generics>market>in>the>Netherlands
- Use>the>Five>Forces>analysis>to>determine>the>competitive>intensity>and>therefore>attractiveness>of>the>generics>market>in>the>Netherlands
- Leading>company>profiles>reveal>details>of>key>generics>market>players’>global>operations>and>financial>performance
- Add>weight>to>presentations>and>pitches>by>understanding>the>future>growth>prospects>of>the>Netherlands>generics>market>with>five>year>forecasts
- What>was>the>size>of>the>Netherlands>generics>market>by>value>in>2024?
- What>will>be>the>size>of>the>Netherlands>generics>market>in>2029?
- What>factors>are>affecting>the>strength>of>competition>in>the>Netherlands>generics>market?
- How>has>the>market>performed>over>the>last>five>years?
- Who>are>the>top>competitors>in>the>Netherlands's>generics>market?
Table of Contents
44 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the strategies of the leading players?
- 8 Company Profiles
- 8.1. Sandoz Group AG
- 8.2. Teva Pharmaceutical Industries Ltd
- 8.3. Viatris Inc
- 8.4. Sanofi
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Netherlands generics market value: $ million, 2019-24
- Table 2: Netherlands generics market volume: % of total pharma volume, 2019-24
- Table 3: Netherlands generics market geography segmentation: $ million, 2024
- Table 4: Netherlands generics market value forecast: $ million, 2024-29
- Table 5: Netherlands generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Sandoz Group AG: Key Facts
- Table 7: Sandoz Group AG: Annual Financial Ratios
- Table 8: Sandoz Group AG: Key Employees
- Table 9: Teva Pharmaceutical Industries Ltd: Key Facts
- Table 10: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 11: Teva Pharmaceutical Industries Ltd: Key Employees
- Table 12: Viatris Inc: Key Facts
- Table 13: Viatris Inc: Annual Financial Ratios
- Table 14: Viatris Inc: Key Employees
- Table 15: Sanofi: Key Facts
- Table 16: Sanofi: Annual Financial Ratios
- Table 17: Sanofi: Key Employees
- Table 18: Sanofi: Key Employees Continued
- Table 19: Netherlands Size of Population (Million), 2020-24
- Table 20: Netherlands Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 21: Netherlands GDP (Current Prices, $ Billion), 2020-24
- Table 22: Netherlands Inflation, 2020-24
- Table 23: Netherlands Consumer Price Index (Absolute), 2020-24
- Table 24: Netherlands Exchange Rate, 2019-24
- List of Figures
- Figure 1: Netherlands generics market value: $ million, 2019-24
- Figure 2: Netherlands generics market volume: % of total pharma volume, 2019-24
- Figure 3: Netherlands generics market geography segmentation: % share, by value, 2024
- Figure 4: Netherlands generics market value forecast: $ million, 2024-29
- Figure 5: Netherlands generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in the Netherlands, 2024
- Figure 7: Drivers of buyer power in the generics market in the Netherlands, 2024
- Figure 8: Drivers of supplier power in the generics market in the Netherlands, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in the Netherlands, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in the Netherlands, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in the Netherlands, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

